Avixgen

Avixgen is a biopharmaceutical developer.Avixgen is developing injectables and eye drops with higher efficacy and fewer side effects as its leading pipeline, primarily for the treatment of macular degeneration. In addition, as a platform concept, Avixgen has developed and is applying the significantly improved drug delivery platform ACP. This platform can conveniently attach to and deliver various drugs such as compounds, antibodies, peptides, and nucleic acids. It excels in improving the solubility of poorly soluble drugs and shows promise for brain disease treatment due to its excellent permeability.